Healthcare
Lowering the Barriers to Entry for Economics Research in Healthcare
A new collection of scholarly work on the economics of the US healthcare sector is released today. The following is an adaptation of the...
Five New Pieces You Should Read from Chicago Booth Review
Chicago Booth Review recently published its fall issue covering a variety of new research. We suggest five articles from the issue on topics of...
Healthcare Companies Spent More on Lobbying Than Any Other Industry Last Year
Threatened by regulated price caps from congress, the pharmaceutical industry spent nearly $390 million on lobbying in 2021 according to new data from OpenSecrets.
Healthcare...
Antitrust Enforcement Is Not Enough to Address Anticompetitive Conduct in Pharmaceutical Markets. Market-Oriented Legal Reform is Needed.
Federal antitrust enforcement has been robust and effective in promoting prescription drug market competition and thereby enhancing consumer welfare. Antitrust enforcement in itself, however,...
Competition Problems in Prescription Drug Market
Although not the sole cause of high prescription drug costs, abusive practices that distort competition contribute to the problem. Too many companies exclude competition...
The Unchecked Market Power of the American Health Care System
Chicago Booth alumnus and retired health care consultant David W. Ennis responds to ProMarket’s recent coverage on antitrust and the US health care system....
Invigorating Competition in Health Care Markets: Is Rate Regulation Needed?
It now appears that market concentration may be the leading cause of America’s health care cost crisis. If the United States is going to...
Opening the Black Box: The Hidden Costs of Data-Driven Mergers in Health Care
Vertical data-driven mergers between health insurers and drug suppliers may facilitate health insurers’ efforts to discriminate against vulnerable populations, leaving them without meaningful access...
What Is the Price of a Prescription Drug?
Due to lack of transparency and mystery rebates, which are considered trade secrets, figuring out the price of a prescription drug is devilishly difficult....
Covid-19 Is Reducing Americans’ Confidence Across Institutions
Latest US household survey findings reveal that the Covid-19 crisis caused a sharp reduction in Americans’ confidence in institutions—whether or not they were directly...
